Skip to main content

Table 1 Clinical features of 497 PRAD patient samples from the TCGA

From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Characteristics

Number (%)

Total

 

497

Age

Median (range)

61 [41, 78]

PSA

Median (range)

0.1 [0, 323]

Gleason score

Primary + secondary

 
 

6

45

 

7

247

 

8

64

 

9

137

 

10

4

T stage

T1

177

 

T2

173

 

T3

53

 

T4

2

 

NA

92

N stage

N0

345

 

N1

79

 

NA

73

M stage

M0

455

 

M1

3

 

NA

39

  1. PRAD prostate adenocarcinoma, NA not applicable